Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-04-26 Purchase | 2021-04-27 4:03 pm | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A President and CEO 10% Owner | 12,000 | $5 | $60,000 | 1,298,344 (Indirect Direct) | View |
| 2020-06-09 Purchase | 2020-06-10 11:50 am | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A Lipizzaner LLC President and CEO 10% Owner | 1,275 | $7.7339 | $9,861 | 2,560,164 (Indirect Direct) | View |
| 2020-05-21 Purchase | 2020-05-26 4:39 pm | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A Lipizzaner LLC President and CEO 10% Owner | 1,250 | $8.0888 | $10,111 | 2,558,889 (Indirect Direct) | View |
| 2020-04-30 Purchase | 2020-05-04 3:25 pm | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A Lipizzaner LLC President and CEO 10% Owner | 10,000 | $6 | $60,000 | 2,557,639 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-02 Exercise | 2023-08-04 4:39 pm | 2019-07-12 2023-12-31 | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A Founder and CEO 10% Owner | 93,234 | $0 | 238,162 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 4:39 pm | N/A N/A | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A Founder and CEO 10% Owner | 93,234 | $0.022 | 238,162 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-17 4:11 pm | N/A N/A | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A CEO and Director 10% Owner | 153,000 | $0 | 2,898,594 (Direct) | View |
| 2023-02-13 Exercise | 2023-02-15 7:30 pm | 2019-07-12 2023-12-31 | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A President and CEO 10% Owner | 655,000 | $0 | 4,610,274 (Direct) | View |
| 2022-09-28 Exercise | 2022-09-30 7:45 pm | 2019-07-12 2023-12-31 | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A CEO 10% Owner | 750,000 | $0.0011 | 4,610,274 (Direct) | View |
| 2022-01-24 Option Award | 2022-01-25 1:50 pm | N/A 2032-01-24 | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A President and CEO 10% Owner | 306,000 | $0 | 306,000 (Direct) | View |
| 2021-12-31 Exercise | 2022-01-05 9:45 pm | 2019-07-12 2028-12-31 | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A President and CEO 10% Owner | 42,250 | $0.001 | 4,610,274 (Direct) | View |
| 2020-12-29 Option Award | 2020-12-30 5:01 pm | N/A 2030-12-29 | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A President and CEO 10% Owner | 164,925 | $0 | 1,451,269 (Direct) | View |
| 2020-11-23 Gift | 2020-12-30 5:01 pm | N/A N/A | NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A President and CEO 10% Owner | 6,369,097 | $0 | 1,451,269 (Indirect) | View |